Progesterone sits directly upstream of testosterone in the body’s hormone-production pathway, which leads many people to assume that taking or producing more progesterone means making more testosterone. In practice, the relationship runs mostly in the opposite direction: progesterone and its synthetic relatives tend to suppress testosterone levels through feedback loops in the brain, and clinical studies generally show no meaningful testosterone increase when progesterone is administered. The full picture, though, involves some genuinely surprising wrinkles depending on sex, tissue type, and whether you’re talking about natural progesterone or a synthetic version.
The Precursor Paradox
Progesterone is a biochemical precursor to testosterone. In steroid hormone production, cholesterol is first converted into pregnenolone, then into progesterone, which is then modified through several enzymatic steps to eventually become testosterone. This is straightforward chemistry, and it’s the reason the question comes up so often: if the body uses progesterone as raw material for testosterone, shouldn’t more progesterone mean more testosterone?
It doesn’t work that way for the same reason that having more flour in your kitchen doesn’t mean you’ll bake more bread. Hormone production is tightly regulated by enzymes at every step, and those enzymes are themselves controlled by signals from the brain. The mere presence of a precursor does not force the pathway forward. In fact, an older study using radioactively labeled progesterone in rat adrenal tissue found that only about 0.01 to 0.04 percent of the added progesterone was converted into testosterone, a tiny fraction that underscores how heavily regulated each step is.1Journal of Steroid Biochemistry. Production of testosterone and corticosteroids by the rat adrenal gland incubated in vitro and the effects of stimulation with ACTH, LH and FSH The bottleneck isn’t the supply of progesterone; it’s the activity of the enzymes downstream and the brain signals that govern them.
How Progesterone Actually Suppresses Testosterone
The dominant effect of progesterone on testosterone, in both men and women, runs through the hypothalamic-pituitary-gonadal (HPG) axis. This is the feedback loop where the brain monitors circulating hormone levels and adjusts the signals it sends to the gonads. Progesterone feeds back to the hypothalamus and pituitary, reducing the release of gonadotropin-releasing hormone and the downstream signals (LH and FSH) that tell the testes or ovaries to produce sex steroids. In men, progesterone’s effects include blocking gonadotropin secretion, which reduces the stimulus for the testes to produce testosterone.2PubMed. Progesterone: the forgotten hormone in men?
This suppressive effect is so reliable that researchers have explored adding a progestin (a synthetic version of progesterone) to testosterone as a form of male hormonal contraception. In one study testing this approach, the addition of a depot progestin to a testosterone formulation markedly increased sperm suppression, with nine out of ten men becoming azoospermic. The progestin wasn’t boosting testosterone; it was helping shut down the brain’s signals to the testes, amplifying the contraceptive effect of the externally provided testosterone.3PubMed. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot
What Happens During the Menstrual Cycle
One reason the progesterone-testosterone connection confuses people is that during the menstrual cycle, both hormones rise and fall in patterns that can look correlated. Progesterone surges during the luteal phase (the second half of the cycle, after ovulation), and testosterone also tends to be slightly higher during this phase compared with the early follicular phase. A study measuring androgen levels across the menstrual cycle in healthy women found that median testosterone reached its lowest point in the early follicular phase (around 0.32 nmol/L) and was modestly higher at midcycle and in the luteal phase (around 0.35 nmol/L).4The Journal of Clinical Endocrinology & Metabolism. Androgens During the Reproductive Years: What Is Normal for Women?
This modest rise in testosterone during the luteal phase doesn’t mean progesterone is causing it. Both hormones are responding to the same upstream signal: the midcycle LH surge that triggers ovulation also stimulates the ovarian cells that produce androgens. The ovary’s theca cells ramp up androgen production in response to LH, and the corpus luteum (the structure left behind after ovulation) produces progesterone. The two hormones rise in tandem because they share a trigger, not because one is driving the other.
Clinical Evidence in Women With PCOS
The clearest clinical test of whether progesterone raises testosterone comes from studies that administer it and then measure what happens to androgen levels. In women with polycystic ovary syndrome, who already have elevated androgens, researchers gave oral micronized progesterone and tracked hormone levels. Total testosterone, free testosterone, sex hormone binding globulin, DHEAS, and androstenedione all remained unchanged after progesterone treatment.5PubMed. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome This is about as direct as you can get: giving progesterone to a population that is already producing excess androgens did not push testosterone any higher.
PCOS itself involves a complicated steroidogenic picture. The ovarian cells in many women with PCOS overexpress the enzymes involved in androgen production, and about two-thirds of PCOS cases show characteristic overresponsiveness to gonadotropin stimulation in terms of androgen output.6Endocrine Reviews. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited Even in that enzyme-rich environment, exogenous progesterone didn’t translate into more testosterone.
Progesterone’s Effect on DHT and 5-Alpha-Reductase
Beyond the HPG axis, progesterone also interferes with the conversion of testosterone into its more potent form, dihydrotestosterone (DHT). The enzyme 5-alpha-reductase performs this conversion, and progesterone is a surprisingly strong inhibitor of it. In a laboratory study using genital skin tissue, progesterone inhibited 5-alpha-reductase activity by about 97 percent at high concentrations.7PubMed. Effects of sex steroids on skin 5 alpha-reductase activity in vitro That’s an in vitro finding at very high doses and shouldn’t be read as what happens when you take a progesterone supplement, but it demonstrates that progesterone’s interaction with the androgen pathway is broadly inhibitory, not stimulatory.
This 5-alpha-reductase inhibition is one of the mechanisms cited in reviews of progesterone’s potential anti-androgen properties. Progesterone is expected to exert moderate anti-androgen action both through HPG axis suppression and through inhibiting testosterone’s conversion to DHT.8PubMed Central. Progesterone in gender-affirming therapy of trans women So rather than boosting androgenic activity, progesterone works against it on two fronts.
Synthetic Progestins Are a Different Story
One major source of confusion is that “progestins” and “progesterone” are not the same thing. Progestins are synthetic compounds designed to mimic progesterone’s effects on the uterus, but they come with their own chemical baggage. Some older progestins, especially those derived from testosterone’s chemical skeleton (the 19-nortestosterone family), can bind directly to androgen receptors and produce androgenic side effects like acne and unwanted hair growth.
How much androgenic activity a progestin carries varies enormously. Research comparing several progestins found that while natural progesterone and norgestimate bind androgen receptors very weakly (around 0.003 to 0.025 times the affinity of DHT), others like levonorgestrel, gestodene, and 3-keto desogestrel bind with much higher affinity, ranging from about 0.12 to 0.22 times that of DHT.9Contraception. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins These progestins don’t increase testosterone levels in the blood, but they can activate the same receptor testosterone uses, producing similar downstream effects in tissues.
Separate work confirmed that multiple progestins bind the androgen receptor with roughly similar affinities to progesterone itself, although specific downstream effects vary.10PubMed Central. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy This distinction matters practically: if you’re on a birth control pill containing levonorgestrel and you’re experiencing androgenic symptoms, the culprit is the progestin directly activating androgen receptors, not a rise in your testosterone levels. The fix would be switching to a less androgenic progestin or one combined with an estrogen that raises sex hormone binding globulin and thereby reduces free testosterone.
How Hormone Therapy Formulations Shift the Picture
The effects also depend on what else is in the hormone therapy formulation. In postmenopausal women, combined estrogen-progestogen therapy using estradiol and norethisterone acetate (a progestin) markedly increased estrogen levels and decreased androgens. Sex hormone binding globulin rose, which binds testosterone and reduces its availability. By contrast, tibolone, a different synthetic hormone, reduced SHBG by about half and actually increased androgen levels.11PubMed. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels–an association with mammographic density The choice of specific compounds and combinations drives whether testosterone goes up, down, or stays flat, and attributing the change to “progesterone” alone misses the complexity.
Gender-Affirming Hormone Therapy
The question of whether progesterone affects testosterone levels comes up frequently in the context of feminizing hormone therapy for trans women. Some clinicians add progesterone to estrogen-based regimens with the hope that it will provide additional testosterone suppression, improve breast development, or both. The evidence on testosterone suppression specifically is limited and mixed. One retrospective study found that trans women receiving progesterone alongside their standard regimen had somewhat higher rates of reaching the goal testosterone level below 55 ng/dL at six and nine months compared with those not on progesterone, but the difference was not statistically significant.12PubMed. Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy
The theoretical basis for expecting some anti-androgen effect is sound, given progesterone’s HPG-axis suppression and 5-alpha-reductase inhibition. But the clinical data hasn’t confirmed a robust, reliable reduction in testosterone from progesterone alone in this population. That doesn’t mean it’s doing nothing; it means the effect, if present, is modest enough that it’s hard to distinguish from normal variation in small studies.
The Leydig Cell In Vitro Finding
One laboratory result does point in the opposite direction. Researchers studying rat Leydig cells (the testicular cells responsible for testosterone production) found that progesterone could stimulate steroidogenesis in a dose-dependent manner through receptors on the cell surface. When progesterone bound these membrane receptors, it triggered an influx of sodium ions and subsequent activation of steroid production.13PubMed. Identification of functional binding sites for progesterone in rat Leydig cell plasma membrane
This sounds like a direct mechanism for progesterone to boost testosterone, and at the level of an isolated cell in a dish, it is. But in a living organism, this local stimulatory effect is overwhelmed by the brain-level suppressive effect. The HPG axis feedback reduces the signals telling those same Leydig cells to work, and the net result in vivo is suppression, not stimulation. It’s a good reminder that what happens in a petri dish doesn’t always predict what happens in the whole body.
Progesterone’s Muscle Effects Without Raising Testosterone
An intriguing finding that sometimes gets misinterpreted as evidence for progesterone raising testosterone is its effect on muscle. In a study of postmenopausal women, progesterone treatment increased muscle protein synthesis by roughly 50 percent, an effect comparable to what testosterone treatment achieved in the same study. Estradiol, meanwhile, did not affect muscle protein synthesis. Progesterone also increased the expression of MYOD1, a gene involved in muscle cell differentiation.14PubMed Central. Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women
This result is striking because it shows progesterone can have an anabolic effect on muscle through its own mechanisms, independent of testosterone. The researchers were not seeing progesterone convert to testosterone and then act on muscle; progesterone was acting on its own receptors. For anyone who encountered this study through a headline like “progesterone builds muscle like testosterone,” it’s easy to misread it as suggesting the two hormones are interchangeable or that progesterone works by becoming testosterone. It doesn’t. It’s doing something genuinely distinct.
Correlations in Other Species
Animal studies sometimes show patterns that look like a positive link between progesterone and testosterone, which can further confuse the picture. In spotted seals, researchers found a moderate positive correlation between testosterone and progesterone concentrations in sexually mature males.15PubMed. Serum testosterone, progesterone, and estradiol concentrations and sexual maturation in spotted seals (Phoca largha) This correlation almost certainly reflects the shared upstream regulation of both hormones by the HPG axis during the breeding season rather than one hormone driving the other. When the brain is signaling for reproductive readiness, both progesterone and testosterone production ramp up together.
When Lab Results Look Wrong
One practical concern worth knowing about is assay cross-reactivity. Common immunoassay tests used to measure testosterone in blood samples can be thrown off by the presence of certain steroid hormones and synthetic progestins. Research on commercial testosterone assays has found that some display a wider range of cross-reactivity than expected, and that norethindrone therapy (a progestin used in some birth control pills and hormone therapy) may interfere with testosterone measurement in women.16BioMed Central / PubMed Central. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction If you’ve started a progestin and your next blood test shows an unexpected testosterone reading, the number might be an artifact of the test rather than a real change in your hormone levels. Mass spectrometry-based tests are more precise and less susceptible to this kind of interference.
Neurosteroid Metabolism in the Brain
Both progesterone and testosterone are metabolized by overlapping enzymes in the brain, where they’re converted into neurosteroids with distinct effects on mood, sleep, and neural protection. The enzyme 5-alpha-reductase, the same one progesterone inhibits in skin tissue, is active in neurons and converts progesterone into a metabolite called DHP, which is then further converted into allopregnanolone (THP), a neurosteroid with calming properties. The balance of these enzyme activities differs between cell types: neurons have higher 5-alpha-reductase activity, while certain glial cells are better at the subsequent step.17PubMed Central. Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved
The reason this matters for the testosterone question is that progesterone and testosterone compete for the same 5-alpha-reductase enzyme. When progesterone occupies the enzyme, it’s not available to convert testosterone into DHT. In the brain, this competition may partly explain why progesterone has neuroprotective effects that seem to run counter to some androgenic pathways. The relationship between these two hormones in neural tissue is less about one boosting or suppressing the other and more about competition for shared enzymatic machinery.